Abstract
S2-5 Predisposition to severe cutaneous ADRS in Europe(Pharmacogenomics in treatment of atopic disease and drug hypersensitivity,English session)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have